次世代がん診断の世界市場

◆英語タイトル:Next generation cancer diagnostics - Global Market Outlook (2015-2022)
◆商品コード:SMRC65142
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:129
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、次世代がん診断の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・次世代がん診断の世界市場:用途別分析/市場規模
・次世代がん診断の世界市場:技術別分析/市場規模
・次世代がん診断の世界市場:機能別分析/市場規模
・次世代がん診断の世界市場:がん種類別分析/市場規模
・次世代がん診断の世界市場:地域別分析/市場規模
・次世代がん診断のアメリカ市場規模予測
・次世代がん診断のヨーロッパ市場規模予測
・次世代がん診断のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period. The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region.
Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-a-chip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot.
Cancer Type Covered:
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Breast Cancer
• Other Cancer Types
Functions Covered:
• Therapeutic Monitoring
• Risk analysis
• Prognostics diagnosis
• Companion Diagnostics
• Cancer Screening
Technologies Covered:
• Platform-Based Diagnostics
o Polymerase Chain Reaction (PCR)
o Next-Generation Sequencing (NGS)
o Microarrays
o In Situ Hybridization (ISH)
o Immunohistochemistry (IHC)
o Flow Cytometry
o Other Technologies
• Instrument-Based
o Diagnostic Imaging
o Ultrasound
o Mammography
• Biopsies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Technology Analysis
3.8 Emerging markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Next Generation Cancer Diagnostics Market, By Application
5.1 Introduction
5.2 Proteomic Analysis
5.3 Epigenetic Analysis
5.4 Genetic Analysis
5.5 Biomarker Development
5.6 CTC Analysis

6 Global Next Generation Cancer Diagnostics Market, By Technology
6.1 Introduction
6.2 Lab-on-a-chip
6.3 DNA Microarrays
6.4 Multiplexed assays
6.5 RT-PCR & Multiplexing
6.6 Protein Microarrays
6.7 Cellular capture and identification
6.8 Next Generation Sequencing
6.9 Benchtop Sequencers
6.10 Other Technologies

7 Global Next Generation Cancer Diagnostics Market, By Function
7.1 Introduction
7.2 Prognosis Diagnostics
7.3 Companion Diagnostics
7.4 Cancer Screening
7.5 Risk Analysis
7.6 Therapeutic Monitoring

8 Global Next Generation Cancer Diagnostics Market, By Cancer Type
8.1 Introduction
8.2 Sex-related tumors
8.2.1 Cervical Cancer
8.2.2 Breast Cancer
8.2.3 Ovarian Cancer
8.2.4 Prostate Cancer
8.3 Blood-born cancers
8.3.1 Myeloma
8.3.2 Leukemia
8.3.3 Lymphoma
8.4 Lung Cancer
8.5 Solid tumors
8.6 Colorectal Cancer
8.7 Other Cancers

9 Global Next Generation Cancer Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Abbott Laboratories
11.2 Agilent Technologies Inc
11.3 GE Healthcare
11.4 Genomic Health Inc.
11.5 Hologic Inc.
11.6 Illumina Inc.
11.7 Johnson & Johnson
11.8 Myriad Genetics Inc.
11.9 Novartis AG
11.10 Opko Health Inc.
11.11 Perkin Elmer Inc.
11.12 Philips Electronics NV
11.13 Qiagen
11.14 Roche Holding AG
11.15 Thermo Fisher Scientific Inc.

List of Tables
Table 1 Global Next Generation Cancer Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 3 Global Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Table 4 Global Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Table 5 Global Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Table 6 Global Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Table 7 Global Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Table 8 Global Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 9 Global Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Table 10 Global Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Table 11 Global Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Table 12 Global Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Table 13 Global Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Table 14 Global Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Table 15 Global Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Table 16 Global Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Table 17 Global Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 18 Global Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Table 19 Global Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Table 20 Global Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 21 Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Table 22 Global Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Table 23 Global Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Table 24 Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Table 25 Global Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Table 26 Global Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 27 Global Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 28 Global Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Table 29 Global Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 30 Global Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Table 31 Global Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Table 32 Global Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Table 33 Global Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Table 34 Global Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 35 Global Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Table 36 Global Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 37 Global Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 38 North America Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 39 North America Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Table 40 North America Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Table 41 North America Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Table 42 North America Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Table 43 North America Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Table 44 North America Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 45 North America Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Table 46 North America Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Table 47 North America Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Table 48 North America Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Table 49 North America Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Table 50 North America Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Table 51 North America Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Table 52 North America Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Table 53 North America Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 54 North America Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Table 55 North America Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Table 56 North America Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 57 North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Table 58 North America Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Table 59 North America Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Table 60 North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Table 61 North America Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Table 62 North America Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 63 North America Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 64 North America Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Table 65 North America Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 66 North America Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Table 67 North America Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Table 68 North America Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Table 69 North America Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Table 70 North America Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 71 North America Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Table 72 North America Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 73 North America Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 74 Europe Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 75 Europe Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Table 76 Europe Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Table 77 Europe Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Table 78 Europe Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Table 79 Europe Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Table 80 Europe Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 81 Europe Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Table 82 Europe Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Table 83 Europe Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Table 84 Europe Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Table 85 Europe Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Table 86 Europe Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Table 87 Europe Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Table 88 Europe Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Table 89 Europe Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 90 Europe Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Table 91 Europe Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Table 92 Europe Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 93 Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Table 94 Europe Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Table 95 Europe Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Table 96 Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Table 97 Europe Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Table 98 Europe Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 99 Europe Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 100 Europe Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Table 101 Europe Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 102 Europe Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Table 103 Europe Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Table 104 Europe Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Table 105 Europe Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Table 106 Europe Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 107 Europe Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Table 108 Europe Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 109 Europe Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 110 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 111 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Table 112 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Table 113 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Table 114 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Table 115 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Table 116 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 117 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Table 118 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Table 119 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Table 120 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Table 121 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Table 122 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Table 123 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Table 124 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Table 125 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 126 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Table 127 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Table 128 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 129 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Table 130 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Table 131 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Table 132 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Table 133 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Table 134 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 135 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 136 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Table 137 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 138 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Table 139 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Table 140 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Table 141 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Table 142 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 143 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Table 144 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 145 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
Table 146 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 147 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN)
Table 148 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN)
Table 149 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN)
Table 150 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN)
Table 151 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN)
Table 152 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 153 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN)
Table 154 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN)
Table 155 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN)
Table 156 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN)
Table 157 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN)
Table 158 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN)
Table 159 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN)
Table 160 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN)
Table 161 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Table 162 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN)
Table 163 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN)
Table 164 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 165 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN)
Table 166 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN)
Table 167 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN)
Table 168 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
Table 169 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN)
Table 170 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN)
Table 171 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Table 172 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN)
Table 173 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN)
Table 174 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN)
Table 175 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN)
Table 176 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN)
Table 177 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN)
Table 178 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Table 179 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN)
Table 180 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Table 181 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)



【レポートのキーワード】

次世代がん診断、がん診断技術、がん検査

★調査レポート[次世代がん診断の世界市場]販売に関する免責事項
★調査レポート[次世代がん診断の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆